Prakt. lékáren. 2009; 5(2): 64-69 [Urolog. pro Praxi, 2008; 9(4): 177-183]
Both urinary and respiratory infections significantly influence the prescribing of antimicrobial agents and, in a feedback manner, lead to
developing resistance to them. In most economically developed countries, urinary tract infections (UTIs) are the second leading type of
infections. A reasonable administration of empiric as well as targeted treatment with antimicrobial agents may affect therapeutic costs
and potential complications and their treatment. Undertreated or untreated infection is likely to have a prolonged or chronic course,
which is also the case with self-therapy based on TV commercials. In addition to higher diagnosis and treatment costs, chronic stages
of disease alter one‘s assertion at work, home, and the community. Moreover, they significantly affect the quality of life of both the sufferer
and his/her family. A high incidence of UTIs is encountered in pregnant women. A different approach to treatment is required and
a whole range of other issues must be addressed concerning UTIs in pregnancy. A different approach is also required in breastfeeding
women who are of little interest to pharmaceutical companies which report treatment safety. Because of this specificity, even health
care professionals tend to provide them with incorrect information. Therefore, this issue is dealt with in more detail.
Published: April 1, 2009 Show citation